trial
as of 2026-07-01Geriatric Psychiatry and Pharmacovigilance
NCTId NCT01858857
at a glance
Phase — · Unknown
Enrollment 4,000 (estimated)
Sponsored by Hannover Medical School
Primary completion 2015-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
4,000 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2013-05
Primary completion
2015-05
Eligibility
ALL · 65 Years
Interventions & indications
Sponsors
Hannover Medical SchoolLead Sponsor
Asklepios Fachklinikum BrandenburgCollaborator
Asklepios Fachklinikum Teupitz für PsychiatrieCollaborator
Krankenhaus HedwigshöheCollaborator
Kompetenznetz TDM KJP e.V.Collaborator
Investigators
3
Helge Frieling, Prof., MDPrincipal Investigator
Sermin Toto, MDStudy Director
Stefan Bleich, MDStudy Chair
Sites
5 total
Berlin, GermanyBrandenburg an der Havel, GermanyHanover, GermanyLubin, GermanyTeupitz, Germany
Facts & assertions
4 sourced
Enrollment
4,000
Phase
NA
Primary Completion Date
2015-05
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
company
collaborator
indication
investigator